Patents by Inventor Rodolfo A. Vasquez

Rodolfo A. Vasquez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5177194
    Abstract: A multi-step process for purifying an immune serum globulin fraction from a crude plasma protein fraction involves precipitating non-serum globulin proteins from an aqueous suspension of the crude plasma protein fraction using a protein precipitant, adding a virus-inactivating agent to the clarified immune serum globulin-containing liquid, absorbing the immune serum globulins onto a cation exchange resin and washing non-serum globulin contaminants from the resin, subjecting the eluate to ultrafiltration to concentrate the immune serum globulins and separate them from low molecular weight species, contacting the concentrate with an anion exchange resin to absorb non-serum globulin contaminants, passing the imune-serum globulins through the anion exchange resin under conditions that leave non-serum globulin contaminants bound to the resin, and subjecting the filtrate to a molecular washing step to produce a purified immune serum globulin fraction.
    Type: Grant
    Filed: February 1, 1990
    Date of Patent: January 5, 1993
    Assignee: Baxter International, Inc.
    Inventors: Maria E. Sarno, Clifford Graf, Gerald Neslund, Sau-Gee Yung, James Burnham, Jean Kim, Rodolfo A. Vasquez
  • Patent number: 4739039
    Abstract: An improved method of recovering antihemophilic factor (AHF) from cryoprecipitated blood plasma is provided. The improved method incorporates the addition of a calcium ion source during the step of cold precipitation of fibrinogen and fibronectin contaminants, as well as the addition of polyethylene glycol (PEG) at one of various stages of the recovery process. PEG may be added during the cold precipitation of fibrinogen and fibronectin, during the precipitation of AHF, or prior to the filtration of AHF solution. The method of the present invention results in a final AHF product having greatly increased solubility, higher specific activity, and lower fibrinogen and fibronectin content.
    Type: Grant
    Filed: July 15, 1987
    Date of Patent: April 19, 1988
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventors: Rodolfo A. Vasquez, Maria E. Co-Sarno, Clifford R. Graf